Judge ruled against Novo Nordisk, allowing Eli Lilly's weight-loss drug ads to continue.
Why it matters
Judge ruled against Novo Nordisk, allowing Eli Lilly's weight-loss drug ads to continue. — impact context not separately stored; see What changed.